Actively Recruiting
Analyses of Cerebrospinalfluid in Patients With Delirium
Led by Oslo University Hospital · Updated on 2024-03-12
700
Participants Needed
1
Research Sites
591 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The current project aims to measure biomarkers in the cerebrospinalfluid (CSF) and serum samples from patients with delirium. We hope to uncover new insights into the pathophysiology of delirium and explore its link to dementia.
CONDITIONS
Official Title
Analyses of Cerebrospinalfluid in Patients With Delirium
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with acute hip fracture
You will not qualify if you...
- Moribund patients
- Lack of consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Leiv Otto Watne
Oslo, Other, Norway, 0671
Actively Recruiting
Research Team
L
Leiv O Watne, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here